CClinicalTrials.gg
CompletedNCT03534167TODAY!Updated Mar 3, 2023

TODAY! A Mobile App Study

An interventional study of TODAY! App and Coaching in Depression, Anxiety, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Completed at 1 site in United States. Open to male participants aged 14 Years to 24 Years. Per ClinicalTrials.gov, last updated 2023-03-03.

Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
14 Years to 24 Years
Sex
Male
01

Study summary

The aim of this study is to conduct a small randomized controlled trial (RCT) for a 10-week mobile phone intervention using principles of Cognitive Behavior Therapy to target general and minority stressors and treat anxiety and depression in young men romantically/sexually attracted to men.

Read the detailed description

Investigators will conduct a double-arm RCT to develop the infrastructure and collection of data needed to power a larger RCT (e.g., rates of consent, retention rates). Clinical outcomes will be assessed for the purpose of detecting unexpected deterioration. Investigators will also collect usability feedback regarding the intervention which may be used to refine the treatment. Usage data will be used to identify under-used lessons and tools and improve their usefulness/appeal. Compliance with assessments will be monitored and used to improve retention protocols.

02

Conditions studied

  • Depression, Anxiety

Browse trials for

Keywords

  • depression
  • anxiety
  • gay
  • youth
  • Cognitive Behavior Therapy
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 22 is below the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Ann & Robert H Lurie Children's Hospital of Chicago is the lead sponsor of 176 studies on the registry; 30 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 24 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  1. Were assigned male at birth and identify as a man
  2. Report romantic/sexual attraction to men;
  3. Ages 14-24 years;
  4. Resides in the Chicago metro area (i.e., Chicago or suburbs of Cook County)
  5. Presents with clinically significant depressive or anxiety symptoms, per a 10+ on the PHQ-9 or 5+ on the GAD-7
  6. Currently owns a mobile phone that is compatible with the intervention application, and believes they will be able to keep using this mobile phone for the next 10 weeks
  7. Fluent in English.

Exclusion criteria

Exclusion Criteria:

  1. Has visual, hearing, voice, or motor impairment that would prevent completion of study procedures or use of the Internet or mobile phone.
  2. Per self-reported history or the Mini-International Neuropsychiatric Interview (MINI) 7 (Adult version for participants ages 17-24 years and Kid version for ages 14-16 years), has ever been diagnosed with a psychotic disorder or bipolar disorder, or is currently diagnosed with obsessive compulsive disorder, or has been diagnosed in the past two years with posttraumatic stress disorder, dissociative disorder, or eating disorder; or evidences another condition that indicates this intervention may be insufficient to meet the youth's needs. If substance abuse disorder is currently present, PI or designated individual will use clinical judgement to determine whether severity/impairment related to substance use indicates this intervention may be insufficient to meet the youth's needs.
  3. Has been hospitalized for psychiatric reasons or has attempted suicide in the last year, or has a score of 4 or more (i.e., "high" to "severe" suicidality) on the Columbia Suicide Severity Rating Scale, or reports non-suicidal self-injury of a nature that suggests this intervention may be insufficient to meet the youth's needs.
  4. Is concurrently participating in another behavioral intervention research study
  5. Reports currently being in DCFS custody and under 21.
  6. Reports currently being in psychotherapy.
  7. Initiation, discontinuation, or adjustment of antidepressant medication in the past 4 weeks. Individuals excluded solely for this reason will be allowed to retake the baseline assessments (and be compensated accordingly) to determine eligibility after they have been on a stable antidepressant regimen for 4 weeks, if the study is still enrolling at that time.
  8. Less than an 8th grade reading level.
  9. Does not have an email address and does not obtain one within 1 week of the telephone screening.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    TODAY! App and Coaching

    RCT participants will be randomized into a 10-week intervention condition during which they will receive the CBT modules through the TODAY! app. In addition to the mobile app, participants will receive coaching from the study Coach who is trained in Motivational Interviewing principles. Participants will complete mood and behavior assessments at 4 time-points over the course of 22 weeks.

    Behavioral: TODAY! App and Coaching

  • No intervention
    Referrals

    RCT participants will be randomized into a 10-week wait-list control condition and will be provided with and encouraged to use mental health and lesbian, gay, bisexual, queer (LGBQ) referrals and resources in the community. Participants will complete mood and behavior assessments at 4 time-points over the course of 22 weeks. After the 22-week post intervention follow-up, control group participants will have the option to receive the intervention, however they will not be administered follow-up assessments or given coaching.

Interventions

  • BehavioralTODAY! App and Coaching

    The TODAY! app uses the skill building structure of Cognitive Behavior Therapy (CBT). The intervention will be divided into "modules," each devoted to a particular skill. Skills addressed within the intervention include increasing social support, engaging in goal-driven behaviors and reducing mood-driven (i.e., avoidance) behaviors, seeking out positive activities, replacing cognitive distortions with more adaptive thinking styles, improving problem-solving skills, reducing avoidance patterns, and increasing alternate coping strategies. The intervention will be supplemented with brief human contact in the form of a motivational coach. The Coach will be trained on the Motivational Interviewing principles upon which the coaching protocol is based.

06

What researchers measure

Primary outcomes

  1. Change in Patient Health Questionnaire (PHQ) 9-items

    The PHQ-9 is a brief validated depression module. This study will measure change in PHQ-9 scores.

    Time frame: Assessed at baseline, 5 weeks, 10 weeks and 22 weeks

  2. Change in Generalized Anxiety Disorder (GAD) 7-item Questionnaire

    The GAD-7 is a brief measure assessing anxiety. This study will measure change in GAD-7 scores.

    Time frame: Assessed at baseline, 5 weeks, 10 weeks and 22 weeks

Secondary outcomes

  1. Usability feedback

    Usability feedback data will be qualitative, and it may be used to refine intervention components rather than formal analysis. Data entered by the participant into the mobile phone application may also be analyzed for utilization patterns and internal improvements.

    Time frame: Assessed at baseline, 5 weeks, 10 weeks and 22 weeks. Data regarding usage will be generated on the back end

07

Study locations

1 site
  • Ann & Robert H. Lurie Children's Hospital of Chicago
    Chicago, Illinois 60614, United States
08

References and documents

Individual participant data

Plan to share: No — Determination made by PI on a case by case basis

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03534167
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Responsible party
Diane Chen (Medical Psychologist, Division of Adolescent Medicine, Ann & Robert H Lurie Children's Hospital of Chicago) — Principal investigator
First posted
May 23, 2018
Start date
Jun 4, 2018
Primary completion
Jun 30, 2022
Completion
Jun 30, 2022
Last update
Mar 3, 2023

Study contacts

Diane Chen, Ph.D.
principal investigator · Ann & Robert H Lurie Children's Hospital of Chicago

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion